References

Bartlett J, Brunner M, Gough K. Deliberate poisoning with dinitrophenol (DNP): an unlicensed weight loss pill. Emerg Med J. 2010; 27:(2)159-160 https://doi.org/10.1136/emj.2008.069401

Bradbury S, Vale J. Phenol and related compounds. In: Bateman N, Jefferson R, Thomas S (eds). Oxford: Oxford University Press;

Colman E. Dinitrophenol and obesity: an early twentieth-century regulatory dilemma. Regul Toxicol Pharmacol. 2007; 48:(2)115-117 https://doi.org/10.1016/j.yrtph.2007.03.006

Cutting WC, Tainter ML. Actions of dinitrophenol. Proc Soc Exper Biol Med. 1932; 29 https://doi.org/10.3181/00379727-29-6315

Food Standards Agency. 2,4-dinitropheno (DNP). 2019. https//www.food.gov.uk/safety-hygiene/24-dinitrophenol-dnp (accessed 3 February 2020)

Grundlingh J, Dargan PI, El-Zanfaly M, Wood DM. 2,4-dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death. J Med Toxicol. 2011; 205-212 https://doi.org/10.1007/s13181-011-0162-6

Harris MO, Cocoran JJ. Toxicological profile for dinitrophenols.Atlanta (GA): Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services; 1995

Holborow A, Purnell RM, Wong JF. Beware the yellow slimming pill: fatal 2,4-dinitrophenol overdose. BMJ Case Rep. 2016; https://doi.org/10.1136/bcr-2016-214689

Kumar S, Barker K, Seger D. Dinitrophenol-induced hyperthermia resolving with dantrolene administration. Clin Toxicol. 2002; 40:599-673

Lu YQ, Jiang JK, Huang WD. Clinical features and treatment in patients with acute 2,4-dinitrophenol poisoning. J Zhejiang Univ Sci B. 2011; 12:(3)189-192 https://doi.org/10.1631/jzus.B1000265

Ma KC, Pino A, Zappetti D. 2,4-dinitrophenol poisoning presenting as a sepsis-like syndrome. J Clin Toxicol. 2017; 7 https://doi.org/10.4172/2161-0495.1000338

National Institutes for Health US National Library of Medicine. 2,4-Dinitrophenol. 2019. https//webwiser.nlm.nih.gov/substance?identifier=2%2C4-Dnp&identifierType=alias&substanceId=3 (accessed 2 February 2020)

Poole Fe, Haining FB. Sudden death from dinitrophenol poisoning: Report of a case with autopsy. JAMA. 1934; 102:1141-1147 https://doi.org/10.1001/jama.1934.02750140027011

Purvine R. Fatal poisoning from sodium dinitrophenol. JAMA. 1936; 107:(25) https://doi.org/10.1001/jama.1936.92770510002008a

Resuscitation Council UK. Adult Advanced Life Support. 2015. https//www.resus.org.uk/resuscitation-guidelines/adult-advanced-life-support/ (accessed 7 Feb 2020)

Siegmueller C, Narasimhaiah R. Fatal 2,4-dinitrophenol poisoning… coming to a hospital near you. Emerg Med J. 2010; 27:(8)639-640 https://doi.org/10.1136/emj.2009.072892

Tainter ML. Treatment of acute dinitrophenol poisoning. JAMA. 1935; 13:(13)1071-1072 https://doi.org/10.1001/jama.1935.92760130002006a

Tainter ML, Stockton AB, Cutting WC. Use of dinitrophenol in obesity and related conditions: a progress report. JAMA. 1933; 19:(19)1472-1475 https://doi.org/10.1001/jama.1933.02740440032009

Deadly DNP. 2018. https//publichealthmatters.blog.gov.uk/2018/08/13/deadly-dnp/ (accessed 2 February 2020)

van Schoor J, Khanderia E, Thorniley A. Dantrolene in not the answer to 2,4-dinitrophenol: more heated debate. BMJ Case Reports. 2018; 11:(1) https://doi.org/10.1136/bcr-2018-225323

van Veenendaal A, Baten A, Pickkers P. Surviving a life-threatening 2,4-DNP intoxication: ‘Almost dying to be thin’. Neth J Med. 2011; 69:(3)

Warthin AS. A fatal case of toxic jaundice caused by dinitrophenol. Bull Int Assoc Med Mus. 1918; 7c:123-126

Fatal poisoning with 2,4-Dinitrophenol: learning via case study

02 February 2020
Volume 12 · Issue 2

Abstract

2,4-Dinitrophenol (DNP) is an industrial chemical. It is illegal to sell it for human consumption in countries including the UK and the US. However, as DNP is available illegally online, accidental or deliberate DNP poisoning may be seen in people using it for weight loss or bodybuilding. Aggressive, multidisciplinary medical management is required to manage the ensuing hyperthermia, respiratory failure, cardiovascular collapse and multi-organ failure; there is a high risk of cardiac arrest. Emergency services should be vigilant in both initiating prompt treatment and alerting the receiving emergency department as well as taking precautions to minimise their own exposure. This case report concerns a deliberate, fatal DNP poisoning and considers DNP's history, resurgence and toxicity management.

After completing this module, the paramedic will be able to:

A26-year-old man presented to the authors' emergency department (ED) in Lancashire at 05:15, having taken a deliberate overdose of 2,4-dinitrophenol (DNP). The patient's medical history was significant for asthma, anxiety, depression and deliberate self-harm. There was also a history of three previous overdoses (of paracetamol and zopiclone), suicidal ideation, severe acne, body dysmorphia and anabolic steroid use. He was known to mental health services.

Collateral history suggested the patient had been taking DNP orally as a bodybuilding supplement. His drug history was significant for allergies to erythromycin and tetracyline (rash) as well as citalopram intolerance (worsening anxiety and insomnia). Repeat prescriptions included diprobase and fluoxetine, though compliance was reportedly poor. The patient's social history included employment as a chef, living with his mother, being an ex-smoker of 5 pack-years and a significant alcohol intake of >160 units/week periodically.

The patient presented to his mother in an agitated state at 04:20, admitting to having deliberately ingested DNP (quantity unknown) at approximately 01:00 in an attempt to end his life. Emergency medical services (EMS) were called for at 04:29, dispatched at 04:31 and were with the patient by 04:51. Time on scene was short given his physical appearance and agitation; EMS observations were notable for a respiratory rate of 44, saturations of 98% on room air, normotension with a capillary refill time <2 seconds, tachycardia at 172 bpm and normothermia. The patient was alert but agitated. The EMS left the scene at 04:58 and arrived at the ED at 05:09, where the patient was admitted directly to a resuscitation bay. The attending EMS personnel had been unable to gain intravenous access or obtain an ECG because of the patient's agitated state.

Subscribe to get full access to the Journal of Paramedic Practice

Thank you for visiting the Journal of Paramedic Practice and reading our archive of expert clinical content. If you would like to read more from the only journal dedicated to those working in emergency care, you can start your subscription today for just £48.

What's included

  • CPD Focus

  • Develop your career

  • Stay informed